We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As its stock market performance in recent days suggests, Israeli
drugmaker Teva could become a major beneficiary of the withdrawal of Irish drugmaker
Elan's novel Tysabri (natalizumab) treatment for multiple sclerosis.
Iran's drug market is characterised by low pricing levels, a result
of government policy to provide universal access to cheap healthcare, involving
the use of strict price controls.
Brazil's drug industry is awaiting details of this year's scheduled
increase to drug prices, mandated by CMED, the pricing unit of local drug regulator
Anvisa.
As the drug industry in Spain awaits the impact of the government's
latest 4.2% price cut this month, the issue is becoming a source of increasing
bitterness.
Medium-sized Indian drugmaker Aurobindo Pharma has announced
that the US FDA has approved its abbreviated new drug application (ANDA) for
a generic version of Metformin, a diabetes therapy marketed by German drug major
Merck KGaA.
The ongoing efforts of both the government and private industry to
expand the global profile of Jordan's small but well-established drug industry
have played a central role in recent sector development.
Although Argentina's drug regulator ANMAT generally provides automatic
marketing approval for all products cleared by the US FDA, the standard of regulation
remains the cause of severe tension between the country's government and the
research-based industry.
German drug major Boehringer Ingelheim has announced positive results
for its Phase III clinical trials of its prospective HIV/AIDS therapy tipranavir.